170 related articles for article (PubMed ID: 17656332)
1. Comparative efficacies of 2 cysteine prodrugs and a glutathione delivery agent in a colitis model.
Oz HS; Chen TS; Nagasawa H
Transl Res; 2007 Aug; 150(2):122-9. PubMed ID: 17656332
[TBL] [Abstract][Full Text] [Related]
2. Antioxidants as novel therapy in a murine model of colitis.
Oz HS; Chen TS; McClain CJ; de Villiers WJ
J Nutr Biochem; 2005 May; 16(5):297-304. PubMed ID: 15866230
[TBL] [Abstract][Full Text] [Related]
3. Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression.
Kwon KH; Murakami A; Tanaka T; Ohigashi H
Biochem Pharmacol; 2005 Feb; 69(3):395-406. PubMed ID: 15652231
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin deficiency protects mice from Dextran sodium sulfate-induced colitis.
Zhong J; Eckhardt ER; Oz HS; Bruemmer D; de Villiers WJ
Inflamm Bowel Dis; 2006 Aug; 12(8):790-6. PubMed ID: 16917234
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of LK 423, a phthalimido-desmuramyl-dipeptide compound, on dextran sulfate sodium-induced colitis in rodents through restoring their interleukin-10 producing capacity.
Moriguchi M; Urabe K; Norisada N; Ochi C; Stalc A; Urleb U; Muraoka S
Arzneimittelforschung; 1999 Feb; 49(2):184-92. PubMed ID: 10083986
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1beta targets interleukin-6 in progressing dextran sulfate sodium-induced experimental colitis.
Kwon KH; Murakami A; Hayashi R; Ohigashi H
Biochem Biophys Res Commun; 2005 Nov; 337(2):647-54. PubMed ID: 16202978
[TBL] [Abstract][Full Text] [Related]
7. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
8. Fasting prevents experimental murine colitis produced by dextran sulfate sodium and decreases interleukin-1 beta and insulin-like growth factor I messenger ribonucleic acid.
Sävendahl L; Underwood LE; Haldeman KM; Ulshen MH; Lund PK
Endocrinology; 1997 Feb; 138(2):734-40. PubMed ID: 9003009
[TBL] [Abstract][Full Text] [Related]
9. Phototherapy with artificial light suppresses dextran sulfate sodium-induced colitis in a mouse model.
Hiratsuka T; Inomata M; Goto S; Oyama Y; Nakano T; Chen CL; Shiraishi N; Noguchi T; Kitano S
J Gastroenterol Hepatol; 2014 Apr; 29(4):749-56. PubMed ID: 24236761
[TBL] [Abstract][Full Text] [Related]
10. L-cysteine supplementation attenuates local inflammation and restores gut homeostasis in a porcine model of colitis.
Kim CJ; Kovacs-Nolan J; Yang C; Archbold T; Fan MZ; Mine Y
Biochim Biophys Acta; 2009 Oct; 1790(10):1161-9. PubMed ID: 19520150
[TBL] [Abstract][Full Text] [Related]
11. Prevention of naphthalene-induced cataract and hepatic glutathione loss by the L-cysteine prodrugs, MTCA and PTCA.
Rathbun WB; Nagasawa HT; Killen CE
Exp Eye Res; 1996 Apr; 62(4):433-41. PubMed ID: 8795461
[TBL] [Abstract][Full Text] [Related]
12. Prodrugs of L-cysteine as protective agents against acetaminophen-induced hepatotoxicity. 2-(Polyhydroxyalkyl)- and 2-(polyacetoxyalkyl)thiazolidine-4(R)-carboxylic acids.
Roberts JC; Nagasawa HT; Zera RT; Fricke RF; Goon DJ
J Med Chem; 1987 Oct; 30(10):1891-6. PubMed ID: 3656363
[TBL] [Abstract][Full Text] [Related]
13. A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice.
Funakoshi T; Yamashita K; Ichikawa N; Fukai M; Suzuki T; Goto R; Oura T; Kobayashi N; Katsurada T; Ichihara S; Ozaki M; Umezawa K; Todo S
J Crohns Colitis; 2012 Mar; 6(2):215-25. PubMed ID: 22325176
[TBL] [Abstract][Full Text] [Related]
14. Brugia malayi cystatin therapeutically ameliorates dextran sulfate sodium-induced colitis in mice.
Khatri V; Amdare N; Tarnekar A; Goswami K; Reddy MV
J Dig Dis; 2015 Oct; 16(10):585-94. PubMed ID: 26358507
[TBL] [Abstract][Full Text] [Related]
15. Effect of ribose cysteine pretreatment on hepatic and renal acetaminophen metabolite formation and glutathione depletion.
Slitt AM; Dominick PK; Roberts JC; Cohen SD
Basic Clin Pharmacol Toxicol; 2005 Jun; 96(6):487-94. PubMed ID: 15910414
[TBL] [Abstract][Full Text] [Related]
16. L-cysteine prodrug protects against cyclophosphamide urotoxicity without compromising therapeutic activity.
Roberts JC; Francetic DJ; Zera RT
Cancer Chemother Pharmacol; 1991; 28(3):166-70. PubMed ID: 1855273
[TBL] [Abstract][Full Text] [Related]
17. Oroxyloside prevents dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB pathway through PPARγ activation.
Wang X; Sun Y; Zhao Y; Ding Y; Zhang X; Kong L; Li Z; Guo Q; Zhao L
Biochem Pharmacol; 2016 Apr; 106():70-81. PubMed ID: 26947454
[TBL] [Abstract][Full Text] [Related]
18. The effect of dietary glutathione and coenzyme Q10 on the prevention and treatment of inflammatory bowel disease in mice.
Liu C; Russell RM; Smith DE; Bronson RT; Milbury PE; Furukawa S; Wang XD; Blumberg JB
Int J Vitam Nutr Res; 2004 Jan; 74(1):74-85. PubMed ID: 15060903
[TBL] [Abstract][Full Text] [Related]
19. Time course for the elevation of glutathione in numerous organs of L1210-bearing CDF1 mice given the L-cysteine prodrug, RibCys.
Roberts JC; Francetic DJ
Toxicol Lett; 1991 Dec; 59(1-3):245-51. PubMed ID: 1755032
[TBL] [Abstract][Full Text] [Related]
20. 6-Gingerol modulates proinflammatory responses in dextran sodium sulfate (DSS)-treated Caco-2 cells and experimental colitis in mice through adenosine monophosphate-activated protein kinase (AMPK) activation.
Chang KW; Kuo CY
Food Funct; 2015 Oct; 6(10):3334-41. PubMed ID: 26263169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
